ALLMedicine™ Hepatitis Center
Research & Reviews 42,282 results
https://doi.org/10.1177/03913988221104834
The International Journal of Artificial Organs; Becker SCDC, Medina-Pestana JO et. al.
Jun 26th, 2022 - Rapid tests (RT) have been widely used for screening of hepatitis C virus (HCV) in general population, but its performance in hemodialysis (HD) patients and mainly in kidney-transplant recipients (RTx) is less known. The aim of this study was to e...
https://doi.org/10.1021/acs.jnatprod.2c00259
Journal of Natural Products; Tong Y, Zhu W et. al.
Jun 25th, 2022 - Nonalcoholic fatty liver disease (NAFLD) represents a class of disorders including hepatic steatosis, steatohepatitis, and liver fibrosis. Previous research suggested that xyloketal B (Xyl-B), a marine-derived natural product, could attenuate the ...
https://doi.org/10.1111/liv.15345
Liver International : Official Journal of the Internation... Soriano V, de Mendoza C et. al.
Jun 25th, 2022 - Hepatitis delta virus (HDV) is a defective agent that only infects individuals with hepatitis B virus (HBV). Around 5-10% of chronic hepatitis B patients worldwide are superinfected with HDV, which means 15-25 million people. Hepatitis delta is th...
https://doi.org/10.1111/apt.17069
Alimentary Pharmacology & Therapeutics; Ko KL, Hung IF et. al.
Jun 25th, 2022 - Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game. Authors' reply.|2022|Ko KL,Hung IF,Leung WK,|
https://doi.org/10.1111/apt.17044
Alimentary Pharmacology & Therapeutics; Gill M, Majumdar A
Jun 25th, 2022 - Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game.|2022|Gill M,Majumdar A,|
Guidelines 105 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013624
Clinical and Molecular Hepatology;
Apr 18th, 2022 - KASL clinical practice guidelines for management of chronic hepatitis B.|2022| ,|therapeutic use,genetics,drug therapy,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979596
MMWR. Morbidity and Mortality Weekly Report; Weng MK, Doshani M et. al.
Apr 1st, 2022 - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in...
https://doi.org/10.1016/j.clinre.2022.101871
Clinics and Research in Hepatology and Gastroenterology; Duclos-Vallée JC, Debray D et. al.
Feb 3rd, 2022 - Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.|2022|Duclos-Vallée JC,Debray D,De Martin E,Beux EL,Louvet A,|diagnosis,drug therapy,pathology,pathology,
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.
Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.
Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...
Drugs 425 results see all →
Clinicaltrials.gov 4,489 results
https://clinicaltrials.gov/ct2/show/NCT01036971
Jun 24th, 2022 - This protocol describes the screening process used by the National Institute on Drug Abuse (NIDA IRP) to assess potential research participants' eligibility for entering protocols of the NIDA/IRP. Through its clinical research protocols, the IRP a...
https://clinicaltrials.gov/ct2/show/NCT01011712
Jun 24th, 2022 - Viral infections in the normal host are usually self-limited as the innate and acquired immune systems mount successful antiviral responses. However, in some instances, apparently immunocompetent persons manifest infections with viruses that would...
https://clinicaltrials.gov/ct2/show/NCT00339911
Jun 24th, 2022 - Background -NCI-Frederick scientists performing in vitro studies involving human specimens have a need for a reliable and consistent source of samples which protects the donor from research risks. Objective -The purpose of this protocol is to esta...
https://clinicaltrials.gov/ct2/show/NCT03520660
Jun 24th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...
https://clinicaltrials.gov/ct2/show/NCT02190253
Jun 24th, 2022 - Hepatitis E virus infection commonly presents as an acute self-limiting hepatitis in the developing world. However there have been reports that chronic hepatitis E may develop in immunocompromised subjects such as renal and liver transplant recipi...
News 5,015 results
https://www.medscape.com/viewarticle/976174
Jun 24th, 2022 - LONDON ― Case numbers of acute hepatitis in children show "a declining trajectory," and COVID-19 and adenovirus remain the most likely, but as yet unproven, causative agents, said experts in an update at the International Liver Congress (ILC) 2022...
https://www.medscape.com/viewarticle/976200
Jun 24th, 2022 - A new analysis from the Centers for Disease Control and Prevention (CDC) provides further details on mysterious cases of pediatric hepatitis identified across the United States. While 45% percent of patients have tested positive for adenovirus inf...
https://www.mdedge.com/neurology/article/255727/headache-migraine/autoimmune-disorder-drugs-top-list-meds-linked-headache
Randy Dotinga
Jun 23rd, 2022 - DENVER – Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contribute to, ac.
https://www.medscape.com/viewarticle/976124
Jun 23rd, 2022 - DENVER, Colorado — Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contrib...
https://www.medscape.com/viewarticle/975925
Jun 22nd, 2022 - NEW YORK (Reuters Health) - Alcohol-associated liver disease is now the most common indication for liver transplant wait-listing among young American adults, researchers say. From 2003 to 2018, the diagnosis of alcoholic liver disease (ALD) as an ...